Insmed Incorporated
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
INSM News
Insmed (INSM) has delivered a strong performance in recent weeks, catching the attention of investors who track momentum in biotech stocks. Shares have climbed...
If you’re wondering what to make of Insmed after its recent run, you’re not alone. It seems like every time you check the stock, it’s making new headlines. With...
TD Cowen raised the firm’s price target on Insmed (INSM) to $193 from $154 and keeps a Buy rating on the shares. The firm noted the company presented its impres...
Analyst ratings
95%
of 20 ratingsMore INSM News
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Insmed, with a price target of $193.00. Elevate Your Investing Strategy: Take ad...
Evercore ISI analyst Gavin Clark-Gartner raised the firm’s price target on Insmed (INSM) to $180 from $110 and keeps an Outperform rating on the shares. The fir...
Below is Validea's guru fundamental report for INSMED INC (INSM). Of the 22 guru strategies we follow, INSM rates highest using our P/B Growth Investor model ba...
Analyst Maxwell Skor of Morgan Stanley maintained a Hold rating on Insmed, retaining the price target of $144.00. Elevate Your Investing Strategy: Take advantag...